Back to database
1.5/5 Very weak evidence

Focus / nootropic evidence brief

Huperzine A

Huperzine A has cognition research in clinical contexts, but direct evidence for gym focus, strength, endurance, or recovery is weak and not ready for recommendation.

Nootropic claims, weak gym case focus 5 linked sources Content audit 2026-05-04

Headline Finding

Exercise-trained crossover data are very limited; most evidence comes from clinical cognition contexts.

Dose Context

Trials use low microgram-range dosing and vary by population; pre-workout blends often obscure the actual contribution.

Important Caveat

Cholinergic side effects, medication interactions, and limited healthy-athlete replication create a high trust risk.

Source Drawer

Linked Research

5 papers and evidence links - audit 2026-05-04
  1. Trial Exercise-trained crossover RCT
  2. Trial Exercise RCT full text
  3. Meta-analysis Alzheimer's meta-analysis
  4. Systematic review Cognition systematic review
  5. Review Ethnopharmacology review

How To Read This Rating

The score reflects evidence that the supplement does its stated job. Some jobs are direct, such as strength, endurance, or recovery; others are indirect, such as sleep, mood, appetite, or health support. A real effect can still receive a cautious practical rating when dose, safety, product quality, or audience fit remain uncertain.

Spot An Evidence Issue?

Send the disputed claim, source link, and why it changes the practical verdict. Corrections that materially affect the claim, dose, caveat, or rating are prioritized.

Report a source or rating issue